Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1993 May;30(5):401–405. doi: 10.1136/jmg.30.5.401

Comparison of genotype and intellectual phenotype in untreated PKU patients.

S J Ramus 1, S M Forrest 1, D B Pitt 1, J A Saleeba 1, R G Cotton 1
PMCID: PMC1016377  PMID: 8320703

Abstract

We have screened 55 untreated phenylketonuria patients from 42 families for common mutations of the phenylalanine hydroxylase gene and determined both causative alleles in 12 families. The correlation between genotype and intellectual phenotype of patients in these families was examined. Our results were compared to a study which predicted phenylalanine hydroxylase activity based on genotype and examined its correlation with the biochemical phenotype of treated patients. Some of the intellectual phenotypes of patients in our study correlated well with the predicted activities. However, we found one family with a genotype expected to have no activity of phenylalanine hydroxylase where the patients were not severely retarded. Major differences in intellectual phenotype were found in patients with the same genotype both between unrelated subjects and within families, suggesting that there is not a simple correlation between genotype and intellectual phenotype.

Full text

PDF
401

Images in this article

403Image
on p.403
403Image
on p.403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apold J., Eiken H. G., Odland E., Fredriksen A., Bakken A., Lorens J. B., Boman H. A termination mutant prevalent in Norwegian haplotype 7 phenylketonuria genes. Am J Hum Genet. 1990 Dec;47(6):1002–1007. [PMC free article] [PubMed] [Google Scholar]
  2. Bachmann B., Lüke W., Hunsmann G. Improvement of PCR amplified DNA sequencing with the aid of detergents. Nucleic Acids Res. 1990 Mar 11;18(5):1309–1309. doi: 10.1093/nar/18.5.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DiLella A. G., Huang W. M., Woo S. L. Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet. 1988 Mar 5;1(8584):497–499. doi: 10.1016/s0140-6736(88)91295-0. [DOI] [PubMed] [Google Scholar]
  4. DiLella A. G., Marvit J., Brayton K., Woo S. L. An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. 1987 May 28-Jun 3Nature. 327(6120):333–336. doi: 10.1038/327333a0. [DOI] [PubMed] [Google Scholar]
  5. DiLella A. G., Marvit J., Lidsky A. S., Güttler F., Woo S. L. Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. 1986 Aug 28-Sep 3Nature. 322(6082):799–803. doi: 10.1038/322799a0. [DOI] [PubMed] [Google Scholar]
  6. DiSilvestre D., Koch R., Groffen J. Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes. Am J Hum Genet. 1991 May;48(5):1014–1016. [PMC free article] [PubMed] [Google Scholar]
  7. Dianzani I., Forrest S. M., Camaschella C., Saglio G., Ponzone A., Cotton R. G. Screening for mutations in the phenylalanine hydroxylase gene from Italian patients with phenylketonuria by using the chemical cleavage method: a new splice mutation. Am J Hum Genet. 1991 Mar;48(3):631–635. [PMC free article] [PubMed] [Google Scholar]
  8. Dworniczak B., Aulehla-Scholz C., Horst J. Phenylalanine hydroxylase gene: silent mutation uncovers evolutionary origin of different alleles. Clin Genet. 1990 Oct;38(4):270–273. doi: 10.1111/j.1399-0004.1990.tb03580.x. [DOI] [PubMed] [Google Scholar]
  9. Dworniczak B., Aulehla-Scholz C., Horst J. Phenylketonuria: detection of a frequent haplotype 4 allele mutation. Hum Genet. 1989 Dec;84(1):95–96. doi: 10.1007/BF00210683. [DOI] [PubMed] [Google Scholar]
  10. Dworniczak B., Grudda K., Stümper J., Bartholomé K., Aulehla-Scholz C., Horst J. Phenylalanine hydroxylase gene: novel missense mutation in exon 7 causing severe phenylketonuria. Genomics. 1991 Jan;9(1):193–199. doi: 10.1016/0888-7543(91)90238-a. [DOI] [PubMed] [Google Scholar]
  11. Eiken H. G., Odland E., Boman H., Skjelkvåle L., Engebretsen L. F., Apold J. Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res. 1991 Apr 11;19(7):1427–1430. doi: 10.1093/nar/19.7.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eisensmith R. C., Woo S. L. Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutat. 1992;1(1):13–23. doi: 10.1002/humu.1380010104. [DOI] [PubMed] [Google Scholar]
  13. Kang E. S., Sollee N. D., Gerald P. S. Results of treatment and termination of the diet in phenylketonuria (PKU). Pediatrics. 1970 Dec;46(6):881–890. [PubMed] [Google Scholar]
  14. Ledley F. D. Clinical application of genotypic diagnosis for phenylketonuria: theoretical considerations. Eur J Pediatr. 1991 Sep;150(11):752–756. doi: 10.1007/BF02026704. [DOI] [PubMed] [Google Scholar]
  15. Lyonnet S., Caillaud C., Rey F., Berthelon M., Frézal J., Rey J., Munnich A. Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet. 1989 Apr;44(4):511–517. [PMC free article] [PubMed] [Google Scholar]
  16. Marvit J., DiLella A. G., Brayton K., Ledley F. D., Robson K. J., Woo S. L. GT to AT transition at a splice donor site causes skipping of the preceding exon in phenylketonuria. Nucleic Acids Res. 1987 Jul 24;15(14):5613–5628. doi: 10.1093/nar/15.14.5613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Okano Y., Eisensmith R. C., Güttler F., Lichter-Konecki U., Konecki D. S., Trefz F. K., Dasovich M., Wang T., Henriksen K., Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991 May 2;324(18):1232–1238. doi: 10.1056/NEJM199105023241802. [DOI] [PubMed] [Google Scholar]
  19. Okano Y., Wang T., Eisensmith R. C., Steinmann B., Gitzelmann R., Woo S. L. Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet. 1990 Jan;46(1):18–25. [PMC free article] [PubMed] [Google Scholar]
  20. Perry T. L., Hansen S., Tischler B., Bunting R., Diamond S. Glutamine depletion in phenylketonuria.A possible cause of the mental defect. N Engl J Med. 1970 Apr 2;282(14):761–766. doi: 10.1056/NEJM197004022821401. [DOI] [PubMed] [Google Scholar]
  21. Pitt D. The natural history of untreated phenylketonuria. Med J Aust. 1971 Feb 13;1(7):378–383. doi: 10.5694/j.1326-5377.1971.tb87588.x. [DOI] [PubMed] [Google Scholar]
  22. Svensson E., Andersson B., Hagenfeldt L. Two mutations within the coding sequence of the phenylalanine hydroxylase gene. Hum Genet. 1990 Aug;85(3):300–304. doi: 10.1007/BF00206750. [DOI] [PubMed] [Google Scholar]
  23. Trefz F. K., Lichter-Konecki U., Konecki D. S., Schlotter M., Bickel H. PKU and NON-PKU hyperphenylalaninemia: differentiation, indication for therapy and therapeutic results. Acta Paediatr Jpn. 1988 Aug;30(4):397–404. doi: 10.1111/j.1442-200x.1988.tb02528.x. [DOI] [PubMed] [Google Scholar]
  24. Tyfield L. A., Meredith A. L., Osborn M. J., Primavesi R., Chambers T. L., Holton J. B., Harper P. S. Genetic analysis of treated and untreated phenylketonuria in one family. J Med Genet. 1990 Sep;27(9):564–568. doi: 10.1136/jmg.27.9.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wang T., Okano Y., Eisensmith R. C., Fekete G., Schuler D., Berencsi G., Nasz I., Woo S. L. Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somat Cell Mol Genet. 1990 Jan;16(1):85–90. doi: 10.1007/BF01650483. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES